320 related articles for article (PubMed ID: 22184405)
1. IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.
Spadaro F; Lapenta C; Donati S; Abalsamo L; Barnaba V; Belardelli F; Santini SM; Ferrantini M
Blood; 2012 Feb; 119(6):1407-17. PubMed ID: 22184405
[TBL] [Abstract][Full Text] [Related]
2. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo.
Accapezzato D; Visco V; Francavilla V; Molette C; Donato T; Paroli M; Mondelli MU; Doria M; Torrisi MR; Barnaba V
J Exp Med; 2005 Sep; 202(6):817-28. PubMed ID: 16157687
[TBL] [Abstract][Full Text] [Related]
4. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
Montealegre S; van Endert PM
Front Immunol; 2018; 9():3098. PubMed ID: 30666258
[TBL] [Abstract][Full Text] [Related]
5. Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells.
Oura J; Tamura Y; Kamiguchi K; Kutomi G; Sahara H; Torigoe T; Himi T; Sato N
Int Immunol; 2011 Apr; 23(4):223-37. PubMed ID: 21421737
[TBL] [Abstract][Full Text] [Related]
6. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
7. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells.
Liu X; Lu L; Yang Z; Palaniyandi S; Zeng R; Gao LY; Mosser DM; Roopenian DC; Zhu X
J Immunol; 2011 Apr; 186(8):4674-86. PubMed ID: 21402891
[TBL] [Abstract][Full Text] [Related]
8. Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.
Horrevorts SK; Duinkerken S; Bloem K; Secades P; Kalay H; Musters RJ; van Vliet SJ; García-Vallejo JJ; van Kooyk Y
Front Immunol; 2018; 9():1231. PubMed ID: 29963041
[TBL] [Abstract][Full Text] [Related]
9. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9.
Simmons DP; Canaday DH; Liu Y; Li Q; Huang A; Boom WH; Harding CV
J Immunol; 2010 Aug; 185(4):2405-15. PubMed ID: 20660347
[TBL] [Abstract][Full Text] [Related]
11. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA.
Kuchtey J; Chefalo PJ; Gray RC; Ramachandra L; Harding CV
J Immunol; 2005 Aug; 175(4):2244-51. PubMed ID: 16081792
[TBL] [Abstract][Full Text] [Related]
13. Rab22a controls MHC-I intracellular trafficking and antigen cross-presentation by dendritic cells.
Cebrian I; Croce C; Guerrero NA; Blanchard N; Mayorga LS
EMBO Rep; 2016 Dec; 17(12):1753-1765. PubMed ID: 27861124
[TBL] [Abstract][Full Text] [Related]
14.
Del Balzo D; Capmany A; Cebrian I; Damiani MT
Front Immunol; 2021; 12():662096. PubMed ID: 33936099
[TBL] [Abstract][Full Text] [Related]
15. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
Ho NI; Camps MGM; de Haas EFE; Ossendorp F
Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
[TBL] [Abstract][Full Text] [Related]
16. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation.
Burgdorf S; Schölz C; Kautz A; Tampé R; Kurts C
Nat Immunol; 2008 May; 9(5):558-66. PubMed ID: 18376402
[TBL] [Abstract][Full Text] [Related]
17. Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells.
Ho NI; Camps MG; Garcia-Vallejo JJ; Bos E; Koster AJ; Verdoes M; van Kooyk Y; Ossendorp F
Immunology; 2021 Nov; 164(3):494-506. PubMed ID: 34110622
[TBL] [Abstract][Full Text] [Related]
18. IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.
Lattanzi L; Rozera C; Marescotti D; D'Agostino G; Santodonato L; Cellini S; Belardelli F; Gavioli R; Ferrantini M
Immunobiology; 2011 May; 216(5):537-47. PubMed ID: 21093097
[TBL] [Abstract][Full Text] [Related]
19. Active dissemination of cellular antigens by DCs facilitates CD8
Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
[TBL] [Abstract][Full Text] [Related]
20. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.
Di Pucchio T; Chatterjee B; Smed-Sörensen A; Clayton S; Palazzo A; Montes M; Xue Y; Mellman I; Banchereau J; Connolly JE
Nat Immunol; 2008 May; 9(5):551-7. PubMed ID: 18376401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
